Beyond the Surface: Exploring the Mind-Skin Dynamics of Psychodermatology
Main Article Content
Abstract
Psychodermatology is an emerging interdisciplinary field that combines dermatology and psychiatry, focusing on the complex interactions between psychological factors and skin disorders. Despite its significance, this area has historically received limited attention due to inadequate training for healthcare professionals. The field is evolving, acknowledging that biological, psychological, and social elements contribute to skin disease development. Recent studies have explored the connections between the skin and nervous system, revealing how these interactions manifest in various skin conditions. Although classifications for psychodermatological disorders exist, there is no consensus on definitions. Many dermatology patients experience secondary psychiatric issues, which are frequently overlooked. It is crucial for dermatologists to be equipped to initiate basic pharmacological treatments, understand various non-pharmacological options, and know when to refer patients to psychiatrists. An integrated approach involving dermatologists, psychiatrists, and psychologists is essential for effectively addressing these complex disorders.
Article Details
How to Cite
CRITON, V. J. Sebastian; THARAKAN, Ann Liza.
Beyond the Surface: Exploring the Mind-Skin Dynamics of Psychodermatology.
Medical Research Archives, [S.l.], v. 12, n. 11, nov. 2024.
ISSN 2375-1924.
Available at: <https://esmed.org/MRA/mra/article/view/6006>. Date accessed: 12 dec. 2024.
doi: https://doi.org/10.18103/mra.v12i11.6006.
Section
Research Articles
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
1. Franca K, Chacon A, Ledon J, Savas J, Nouri K. Pyschodermatology: a trip through history. An Bras Dermatol. 2013;88(5):842-843. doi:10.1590/abd1806-4841.20132059
2. Kleisiaris CF, Sfakianakis C, Papathanasiou IV. Health care practices in ancient Greece: The Hippocratic ideal. J Med Ethics Hist Med. 2014;7:6. Published 2014 Mar 15.
3. Brown GE, Malakouti M, Sorenson E, Gupta R, Koo JYM. Psychodermatology. In: Balon R, Wise TN, eds. Advances in Psychosomatic Medicine. Vol 34. S. Karger AG; 2015:123-134. doi:10.1159/000369090
5. Freudenmann RW, Lepping P. Delusional infestation. Clin Microbiol Rev. 2009;22(4):690-732. doi:10.1128/CMR.00018-09
6. Grant JE, Odlaug BL, Chamberlain SR, Keuthen NJ, Lochner C, Stein DJ. Skin picking disorder. Am J Psychiatry. 2012;169(11):1143-1149. 59/000. doi:10.1176/appi.ajp.2012.12040508
7. França K, Castillo DE, Roccia MG, Lotti T, Wollina U, Fioranelli M. Psychoneurocutaneous medicine: past, present and future. Wien Med Wochenschr. 2017;167(S1):31-36. doi:10.1007/s10354-017-0573-3
8. Picardi A, Abeni D, Melchi CF, Puddu P, Pasquini P. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol. 2000;143(5):983-991. doi:10.1046/j.1365-2133.2000.03831.x
9. Filaković P, Biljan D, Petek A. Depression in dermatology: an integrative perspective. Psychiatr Danub. 2008;20(3):419-425.
10. Wang J, Wu X, Lai W, et al. Prevalence of depression and depressive symptoms among outpatients: a systematic review and meta-analysis. BMJ Open. 2017;7(8):e017173. doi:10.1136/bmjopen-2017-017173
11. Balieva F, Abebe DS, Dalgard FJ, Lien L. Risk of developing psychiatric disease among adult patients with skin disease: a 9‐year national register follow‐up study in Norway. Skin Health and Disease. 2023;3(6):e294. doi:10.1002/ski2.294
12. Van Beugen S, Schut C, Kupfer J, et al. Perceived stigmatization among dermatological outpatients compared with controls: an observational multicentre study in 17 european countries. Acta Derm Venereol. 2023;103:adv6485. doi:10.2340/actadv.v103.6485
13. Dietel FA, Möllmann A, Bürkner PC, Wilhelm S, Buhlmann U. Interpretation bias across body dysmorphic, social anxiety and generalized anxiety disorder—a multilevel, diffusion model account. Cogn Ther Res. 2021;45(4):715-729. doi:10.1007/s10608-020-10180-7
14. Dalgard FJ, Svensson Å, Gieler U, et al. Dermatologists across Europe underestimate depression and anxiety: results from 3635 dermatological consultations. Br J Dermatol. 2018;179(2):464-470. doi:10.1111/bjd.16250
15. Roberts JE, Smith AM, Wilkerson AH, et al. "Psychodermatology" knowledge, attitudes, and practice among health care professionals. Arch Dermatol Res. 2020;312(8):545-558. doi:10.1007/s00403-020-02050-9
16. Shenefelt PD. Psychodermatological disorders: recognition and treatment. Int J Dermatol. 2011;50(11):1309-1322. doi:10.1111/j.1365-4632.2011.05096.x
17. Mercan S, Kivanç Altunay I. Psikiyatri ve dermatolojinin ortak calişma alani: Psikodermatoloji [Psychodermatology: a collaboration between psychiatry and dermatology]. Turk Psikiyatri Derg. 2006;17(4):305-313.
18. Shastri M, Sharma M, Sharma K, et al. Cutaneous-immuno-neuro-endocrine (CINE) system: a complex enterprise transforming skin into a super organ. Exp Dermatol. 2024;33(3):e15029.
19. Jin R, Luo L, Zheng J. The trinity of skin: skin homeostasis as a neuro–endocrine–immune organ. Life. 2022;12(5):725. doi:10.3390/life12050725
20. Kim J, Cho B, Cho D, Park H. Expression of hypothalamic–pituitary–adrenal axis in common skin diseases: evidence of its association with stress-related disease activity. Acta Derm Venerol. 2013;93(4):387-393. doi:10.2340/00015555-1557
21. Slominski A. Neuroendocrinology of the skin. Endocrine Reviews. 2000;21(5):457-487. doi:10.1210/er.21.5.457.
22. Arck PC, Slominski A, Theoharides TC, Peters EMJ, Paus R. Neuroimmunology of stress: skin takes center stage. Journal of Investigative Dermatology. 2006;126(8):1697-1704. doi:10.1038/sj.jid.5700104.
23. Slominski A, Wortsman J, Kohn L, et al. Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin. J Invest Dermatol. 2002;119(6):1449-1455. doi:10.1046/j.1523-1747.2002.19617.x
24. Park HJ, Kim HJ, Lee JH, et al. Corticotropin-releasing hormone (Crh) downregulates interleukin-18 expression in human hacat keratinocytes by activation of p38 mitogen-activated protein kinase (mapk) pathway. Journal of Investigative Dermatology. 2005;124(4):751-755. doi:10.1111/j.0022-202X.2005.23656.x
25. Dhabhar FS. Stress, leukocyte trafficking, and the augmentation of skin immune function. Ann N Y Acad Sci. 2003;992:205-217. doi:10.1111/j.1749-6632.2003.tb03151.x
26. Aguilera G. HPA axis responsiveness to stress: implications for healthy aging. Exp Gerontol. 2011;46(2-3):90-95. doi:10.1016/j.exger.2010.08.023
27. Glaser R, MacCallum RC, Laskowski BF, Malarkey WB, Sheridan JF, Kiecolt-Glaser JK. Evidence for a shift in the th-1 to th-2 cytokine response associated with chronic stress and aging. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 2001;56(8):M477-M482. doi:10.1093/gerona/56.8.M477
28. Dhabhar FS. Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology. Neuroimmunomodulation. 2009;16(5):300-317. doi:10.1159/000216188
29. Tausk F, Elenkov I, Moynihan J. Psychoneuroimmunology. Dermatol Ther. 2008;21(1): 22-31. doi:10.1111/j.1529-8019.2008.00166.x
30. Fortune DG, Richards HL, Griffiths CE. Psychologic factors in psoriasis: consequences, mechanisms, and interventions. Dermatol Clin. 2005;23(4):681-694. doi:10.1016/j.det.2005.05.022
31. Buske-Kirschbaum A, Ebrecht M, Hellhammer DH. Blunted HPA axis responsiveness to stress in atopic patients is associated with the acuity and severeness of allergic inflammation. Brain Behav Immun. 2010;24(8):1347-1353. doi:10.1016/j.bbi.2010.06.013
32. Lotti T, Zanardelli M, D'Erme AM. Vitiligo: what's new in the psycho-neuro-endocrine-immune connection and related treatments. Wien Med Wochenschr. 2014;164(13-14):278-285. doi:10.1007/s10354-014-0288-7
33. Ruocco V, Ruocco E, Lo Schiavo A, Brunetti G, Guerrera LP, Wolf R. Pemphigus: etiology, pathogenesis, and inducing or triggering factors: facts and controversies. Clin Dermatol. 2013;31(4):374-381. doi:10.1016/j.clindermatol.2013.01.004
34. Morell-Dubois S, Carpentier O, Cottencin O, et al. Stressful life events and pemphigus. Dermatology. 2008;216(2):104-108. doi:10.1159/000111506
35. Jović A, Marinović B, Kostović K, Čeović R, Basta-Juzbašić A, Bukvić Mokos Z. The impact of pyschological stress on acne. Acta Dermatovenerol Croat. 2017;25(2):1133-1141.
36. Mar K, Rivers JK. The mind body connection in dermatologic conditions: a literature review. J Cutan Med Surg. 2023;27(6):628-640. doi:10.1177/12034754231204295
37. Ahn D, Kim H, Lee B, Hahm DH. Psychological stress-induced pathogenesis of alopecia areata: autoimmune and apoptotic pathways. IJMS. 2023;24(14):11711. doi:10.3390/ijms241411711
38. Konstantinou GN, Konstantinou GN. Psychological stress and chronic urticaria: a neuro-immuno-cutaneous crosstalk. A systematic review of the existing evidence. Clinical Therapeutics. 2020;42(5):771-782. doi:10.1016/j.clinthera.2020.03.010
39. Chida Y, Mao X. Does psychosocial stress predict symptomatic herpes simplex virus recurrence? A meta-analytic investigation on prospective studies. Brain, Behavior, and Immunity. 2009;23(7):917-925. doi:10.1016/j.bbi.2009.04.009
40. Maarouf M, Maarouf CL, Yosipovitch G, Shi VY. The impact of stress on epidermal barrier function: an evidence-based review. Br J Dermatol. 2019;181(6):1129-1137. doi:10.1111/bjd.17605
41. Altemus M, Rao B, Dhabhar FS, Ding W, Granstein RD. Stress-induced changes in skin barrier function in healthy women. J Invest Dermatol. 2001;117(2):309-317. doi:10.1046/j.1523-1747.2001.01373.x
42. Arck P, Handjiski B, Hagen E, et al. Is there a 'gut-brain-skin axis'?. Exp Dermatol. 2010;19(5):401-405. doi:10.1111/j.1600-0625.2009.01060.x
43. Söderholm JD, Perdue MH. Stress and gastrointestinal tract. II. Stress and intestinal barrier function. Am J Physiol Gastrointest Liver Physiol. 2001;280(1):G7-G13. doi:10.1152/ajpgi.2001.280.1.G7
44. Ferreira BR, Jafferany M. Classification of psychodermatological disorders. J Cosmet Dermatol. 2021;20(6):1622-1624. doi:10.1111/jocd.14112
45. Ferreira BR, Vulink N, Mostaghimi L, et al. Classification of psychodermatological disorders: Proposal of a new international classification. Acad Dermatol Venereol. 2024;38(4):645-656. doi:10.1111/jdv.19731
46. Mehta H, Narang T. Evaluation and approach to patients with psychodermatoses. Clin Dermatol Rev. 2023;7(4):310-318. doi:10.4103/cdr.cdr_3_22
47. Jafferany M, Franca K. Psychodermatology: basics concepts. Acta Derm Venereol. 2016;96(217):35-37. doi:10.2340/00015555-2378
48. Koo J, Lebwohl A. Psycho dermatology: the mind and skin connection. Am Fam Physician. 2001;64(11):1873-1878.
49. Reichenberg JS, Kroumpouzos G, Magid M. Approach to a psychodermatology patient. G Ital Dermatol Venereol. 2018;153(4):494-496. doi:10.23736/S0392-0488.18.05965-5.
50. Marshall C, Taylor R, Bewley A. Psychodermatology in clinical practice: main principles. Acta Derm Venereol. 2016;96(217):30-34. doi:10.2340/00015555-2370
51. Torales J, García O, Barrios I, et al. Delusional infestation: clinical presentations, diagnosis, and management. J Cosmet Dermatol. 2020;19(12):3183-3188. doi:10.1111/jocd.13786
52. Campbell EH, Elston DM, Hawthorne JD, Beckert DR. Diagnosis and management of delusional parasitosis. J Am Acad Dermatol. 2019;80(5):1428-1434. doi:10.1016/j.jaad.2018.12.012
53. Beuerlein KG, Balogh EA, Feldman SR. Morgellons disease etiology and therapeutic approach: a systematic review. Dermatol Online J. 2021;27(8). doi:10.5070/D327854682
54. Wong S, Bewley A. Patients with delusional infestation (delusional parasitosis) often require prolonged treatment as recurrence of symptoms after cessation of treatment is common: an observational study. Br J Dermatol. 2011;165(4):893-896. doi:10.1111/j.1365-2133.2011.10426.x
55. American Psychiatric Association, ed. Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR. Fifth edition, text revision. American Psychiatric Association Publishing; 2022.
56. Phillips KA, Menard W, Pagano ME, Fay C, Stout RL. Delusional versus nondelusional body dysmorphic disorder: clinical features and course of illness. J Psychiatr Res. 2006;40(2):95-104. doi:10.1016/j.jpsychires.2005.08.005
57. Pereira IN, Chattopadhyay R, Fitzpatrick S, Nguyen S, Hassan H. Evidence-based review: Screening body dysmorphic disorder in aesthetic clinical settings. J Cosmet Dermatol. 2023;22(7):1951-1966. doi:10.1111/jocd.15685
58. McGrath LR, Oey L, McDonald S, Berle D, Wootton BM. Prevalence of body dysmorphic disorder: A systematic review and meta-analysis. Body Image. 2023;46:202-211. doi:10.1016/j.bodyim.2023.06.008
59. Eskander N, Limbana T, Khan F. Psychiatric comorbidities and the risk of suicide in obsessive-compulsive and body dysmorphic disorder. Cureus. 2020;12(8):e9805. Published 2020 Aug 17. doi:10.7759/cureus.9805
60. Hong K, Nezgovorova V, Uzunova G, Schlussel D, Hollander E. Pharmacological treatment of body dysmorphic disorder. Curr Neuropharmacol. 2019;17(8):697-702. doi:10.2174/1570159X16666180426153940
61. Grant JE, Stein DJ. Body-focused repetitive behavior disorders in ICD-11. Braz J Psychiatry. 2014;36 Suppl 1:59-64. doi:10.1590/1516-4446-2013-1228
62. Hautmann G, Hercogova J, Lotti T. Trichotillomania. J Am Acad Dermatol. 2002;46(6):807-826. doi:10.1067/mjd.2002.122749
63. Torales J, Ruiz Díaz N, Ventriglio A, et al. Hair-pulling disorder (Trichotillomania): etiopathogenesis, diagnosis and treatment in a nutshell. Dermatol Ther. 2021;34(1):e13466. doi:10.1111/dth.14366
64. Grant JE, Chamberlain SR. Trichotillomania. Am J Psychiatry. 2016;173(9):868-874. doi:10.1176/appi.ajp.2016.15111432
65. Jafferany M, Mkhoyan R, Stamu-O'Brien C, Carniciu S. Nonpharmacological treatment approach in trichotillomania (hair-pulling disorder). Dermatol Ther. 2020;33(4):e13622. doi:10.1111/dth.13622
66. Henkel ED, Jaquez SD, Diaz LZ. Pediatric trichotillomania: review of management. Pediatr Dermatol. 2019;36(6):803-807. doi:10.1111/pde.13954
67. Everett GJ, Jafferany M, Skurya J. Recent advances in the treatment of trichotillomania (hair-pulling disorder). Dermatol Ther. 2020;33(6):e13818. doi:10.1111/dth.13818
68. Hoffman J, Williams T, Rothbart R, et al. Pharmacotherapy for trichotillomania. Cochrane Database Syst Rev. 2021;9(9). doi:10.1002/14651858.CD007662.pub3
69. Odlaug BL, Grant JE. Phenomenology and epidemiology of pathological skin picking. In: Grant JE, Potenza MN, eds. The Oxford Handbook of Impulse Control Disorders. 1st ed. Oxford University Press; 2012:187-195. doi:10.1093/oxfordhb/9780195389715.013.0070
70. Flessner CA, Woods DW. Phenomenological characteristics, social problems, and the economic impact associated with chronic skin picking. Behav Modif. 2006;30(6):944-963. doi:10.1177/0145445506294083
71. Odlaug BL, Grant JE. Clinical characteristics and medical complications of pathologic skin picking. Gen Hosp Psychiatry. 2008;30(1):61-66. doi:10.1016/j.genhosppsych.2007.07.009
72. Torales J, Díaz NR, Barrios I, et al. Psychodermatology of skin picking (excoriation disorder): A comprehensive review. Dermatol Ther. 2020;33(4):e13661. doi:10.1111/dth.13661
73. Lochner C, Roos A, Stein DJ. Excoriation (skin-picking) disorder: a systematic review of treatment options. Neuropsychiatr Dis Treat. 2017;13:1867-1872.
74. Chandran V, Kurien G. Dermatitis artefacta. In: StatPearls. StatPearls Publishing; 2024. Accessed October 4, 2024. http://www.ncbi.nlm.nih.gov/books/NBK430936/
75. Mohandas P, Ravenscroft JC, Bewley A. Dermatitis artefacta in childhood and adolescence: a spectrum of disease. G Ital Dermatol Venereol. 2018;153(4):525-534. doi:10.23736/S0392-0488.18.06019-4
76. Verraes-Derancourt S, Derancourt C, Poot F, Heenen M, Bernard P. Dermatitis artefacta: retrospective study in 31 patients. Ann Dermatol Venereol. 2006;133(3):235-8. doi:10.1016/S0151-9638(06)70886-9
77. Koblenzer CS. Dermatitis artefacta. Clinical features and approaches to treatment. Am J Clin Dermatol. 2000;1(1):47-55. doi:10.2165/00128071-200001010-00005
78. Alozai U ullah, McPherson PK. Malingering. In: StatPearls. StatPearls Publishing; 2024. Accessed August 1, 2024. http://www.ncbi.nlm.nih.gov/books/NBK507837/
79. Marzouki-Zerouali A, Schoeffler A, Liegeon AL, Le Vaou P, Truchetet F. Lésions auto-provoquées dans un contexte d’hidradénite suppurée : un cas de pathomimicrie [Self-inflicted lesions in the context of hidradenitis suppurativa: Pathomimicry]. Annales de Dermatologie et de Vénéréologie. 2019;146(2):135-140. doi:10.1016/j.annder.2018.07.028
80. Hariharasubramony A, Chankramath S, Srinivasa S. Munchausen syndrome as dermatitis simulata. Indian J Psychol Med. 2012;34(1):94-96. doi:10.4103/0253-7176.96171
81. Nayak K, Gopinath H, Kini H, Kumar P. Unmasking Diogenes syndrome. Indian J Dermatol. 2015;60(3):287-289. doi:10.4103/0019-5154.156385
82. Bonamonte D, Foti C, DE Marco A, et al. Self-inflicted pathological cutaneous disorders. Part I. Ital J Dermatol Venerol. 2022;157(5):389-401. doi:10.23736/S2784-8671.22.07273-5
83. Brown RC, Plener PL. Non-suicidal self-injury in adolescence. Curr Psychiatry Rep. 2017;19(3):20. doi:10.1007/s11920-017-0767-9
84. Misery L, Alexandre S, Dutray S, et al. Functional itch disorder or psychogenic pruritus: suggested diagnosis criteria from the French psychodermatology group. Acta Derm Venereol. 2007;87(4):341-344. doi:10.2340/00015555-0266
85. Gieler U, Niemeier V, Brosig B, Kupfer J. Psychosomatic aspects of pruritus. Dermatol Psychosom. 2002;3(1):6-13. doi:10.1159/000051357
86. Salari N, Heidarian P, Hosseinian-Far A, Babajani F, Mohammadi M. Global prevalence of anxiety, depression, and stress among patients with skin diseases: a systematic review and meta-analysis. J of Prevention. 2024;45(4):611-649. doi:10.1007/s10935-024-00784-0
87. Dalgard FJ, Gieler U, Tomas-Aragones L, et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol. 2015;135(4):984-991. doi:10.1038/jid.2014.530
88. Picardi A, Mazzotti E, Pasquini P. Prevalence and correlates of suicidal ideation among patients with skin disease. J Am Acad Dermatol. 2006;54(3):420-426. doi:10.1016/j.jaad.2005.11.1103
89. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol. 1998;139(5):846-850. doi:10.1046/j.1365-2133.1998.02511.x
90. Alharbi M. Identifying patients at higher risk of depression among patients with vitiligo at outpatient setting. Mater Sociomed. 2020;32(2):108. doi:10.5455/msm.2020.32.108-111
91. Molla A, Jannadi R, Alayoubi H, Altouri H, Balkhair M, Hafez D. Assessing the relationship between vitiligo and major depressive disorder severity: cross-sectional study. JMIR Dermatol. 2024;7:e60686. doi:10.2196/60686
92. Bakar RS, Jaapar SZS, Azmi AF, Aun YC. Depression and anxiety among patients with psoriasis: A correlation with quality of life and associated factors. J Taibah Univ Med Sci. 2021;16(4):491-496. doi:10.1016/j.jtumed.2021.02.008
93. Mostafa N, Smith SD. Improving psychological health outcomes in children with atopic dermatitis. Clin Cosmet Investig Dermatol. 2023;16:2821-2827. doi:10.2147/CCID.S393254
94. Holmes A, Marella P, Rodriguez C, Glass, Ii D, Goerlich KS. Alexithymia and cutaneous disease morbidity: a systematic review. Dermatology. 2022;238(6):1120-1129. doi:10.1159/000524736
95. Balon R, Wise TN, eds. Clinical Challenges in the Biopsychosocial Interface: Update on Psychosomatics for the 21st Century. Karger; 2015.
96. Yadav S, Narang T, Kumaran MS. Psychodermatology: a comprehensive review. Indian J Dermatol Venereol Leprol. 2013;79(2):176-192. doi:10.4103/0378-6323.107632
97. D'Erme AM, Zanieri F, Campolmi E, et al. Therapeutic implications of adding the psychotropic drug escitalopram in the treatment of patients suffering from moderate-severe psoriasis and psychiatric comorbidity: a retrospective study. J Eur Acad Dermatol Venereol. 2014;28(2):246-249. doi:10.1111/j.1468-3083.2012.04690.x
98. Voss RM, Das JM. Mental status examination. In: StatPearls. StatPearls Publishing; 2024. Accessed October 5, 2024. http://www.ncbi.nlm.nih.gov/books/NBK546682/
99. Jafferany M, Ferreira BR, Abdelmaksoud A, Mkhoyan R. Management of psychocutaneous disorders: A practical approach for dermatologists. Dermatol Ther. 2020;33(6):e13969. doi:10.1111/dth.13969
100. Patel A, Jafferany M. Multidisciplinary and holistic models of care for patients with dermatologic disease and psychosocial comorbidity: a systematic review. JAMA Dermatol. 2020;156(6):686. doi:10.1001/jamadermatol.2020.0394
101. Ferreira BR, Pio‐Abreu JL, Reis JP, Figueiredo A. First psychodermatology clinic in a portuguese department of dermatology. Acad Dermatol Venereol. 2019;33(3). doi:10.1111/jdv.15303
102. Poot F, Sampogna F, Onnis L. Basic knowledge in psychodermatology. J Eur Acad Dermatol Venereol. 2007;21(2):227-234. doi:10.1111/j.1468-3083.2006.01910.x
103. Shenoi SD, Prabhu S, Nirmal B, Petrolwala S. Our experience in a psychodermatology liaison clinic at manipal, India. Indian J Dermatol. 2013;58(1):53-55. doi:10.4103/0019-5154.105310
104. Goyal N, Shenoi S, Prabhu SS, Sreejayan K, Munoli R, Rai S. Psychodermatology liaison clinic in India: a working model. Trop Doct. 2018;48(1):7-11. doi:10.1177/0049475517736708
105. Seale L, Gaulding JV, Porto D, Prabhakar D, Kerr H. Implementation of a psychodermatology clinic at a major health system in Detroit. Int J Women’s Dermatol. 2018;4(4):227-229. doi:10.1016/j.ijwd.2018.05.002
106. Healy R, Taylor R, Dhoat S, Leschynska E, Bewley AP. Management of patients with delusional parasitosis in a joint dermatology/ liaison psychiatry clinic. Br J Dermatol. 2009;161(1):197-199. doi:10.1111/j.1365-2133.2009.09183.x
107. Altaf K, Mohandas P, Marshall C, Taylor R, Bewley A. Managing patients with delusional infestations in an integrated psychodermatology clinic is much more cost-effective than a general dermatology or primary care setting. Br J Dermatol. 2017;177(2):544-545. doi:10.1111/bjd.15088
108. Christensen RE, Jafferany M. Unmet Needs in Psychodermatology: A Narrative Review. CNS Drugs. 2024;38(3):193-204. doi:10.1007/s40263-024-01068-1
109. Altaha L, Jafferany M, Khan A. Psychocutaneous medicine in iraq: current status and recommendations. Prim Care Companion CNS Disord. 2022;24(2). doi:10.4088/PCC.21m03077
110. Jafferany M, Vander Stoep A, Dumitrescu A, Hornung RL. The knowledge, awareness, and practice patterns of dermatologists toward psychocutaneous disorders: results of a survey study. Int J Dermatol. 2010;49(7):784-789. doi:10.1111/j.1365-4632.2009.04372.x
2. Kleisiaris CF, Sfakianakis C, Papathanasiou IV. Health care practices in ancient Greece: The Hippocratic ideal. J Med Ethics Hist Med. 2014;7:6. Published 2014 Mar 15.
3. Brown GE, Malakouti M, Sorenson E, Gupta R, Koo JYM. Psychodermatology. In: Balon R, Wise TN, eds. Advances in Psychosomatic Medicine. Vol 34. S. Karger AG; 2015:123-134. doi:10.1159/000369090
5. Freudenmann RW, Lepping P. Delusional infestation. Clin Microbiol Rev. 2009;22(4):690-732. doi:10.1128/CMR.00018-09
6. Grant JE, Odlaug BL, Chamberlain SR, Keuthen NJ, Lochner C, Stein DJ. Skin picking disorder. Am J Psychiatry. 2012;169(11):1143-1149. 59/000. doi:10.1176/appi.ajp.2012.12040508
7. França K, Castillo DE, Roccia MG, Lotti T, Wollina U, Fioranelli M. Psychoneurocutaneous medicine: past, present and future. Wien Med Wochenschr. 2017;167(S1):31-36. doi:10.1007/s10354-017-0573-3
8. Picardi A, Abeni D, Melchi CF, Puddu P, Pasquini P. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol. 2000;143(5):983-991. doi:10.1046/j.1365-2133.2000.03831.x
9. Filaković P, Biljan D, Petek A. Depression in dermatology: an integrative perspective. Psychiatr Danub. 2008;20(3):419-425.
10. Wang J, Wu X, Lai W, et al. Prevalence of depression and depressive symptoms among outpatients: a systematic review and meta-analysis. BMJ Open. 2017;7(8):e017173. doi:10.1136/bmjopen-2017-017173
11. Balieva F, Abebe DS, Dalgard FJ, Lien L. Risk of developing psychiatric disease among adult patients with skin disease: a 9‐year national register follow‐up study in Norway. Skin Health and Disease. 2023;3(6):e294. doi:10.1002/ski2.294
12. Van Beugen S, Schut C, Kupfer J, et al. Perceived stigmatization among dermatological outpatients compared with controls: an observational multicentre study in 17 european countries. Acta Derm Venereol. 2023;103:adv6485. doi:10.2340/actadv.v103.6485
13. Dietel FA, Möllmann A, Bürkner PC, Wilhelm S, Buhlmann U. Interpretation bias across body dysmorphic, social anxiety and generalized anxiety disorder—a multilevel, diffusion model account. Cogn Ther Res. 2021;45(4):715-729. doi:10.1007/s10608-020-10180-7
14. Dalgard FJ, Svensson Å, Gieler U, et al. Dermatologists across Europe underestimate depression and anxiety: results from 3635 dermatological consultations. Br J Dermatol. 2018;179(2):464-470. doi:10.1111/bjd.16250
15. Roberts JE, Smith AM, Wilkerson AH, et al. "Psychodermatology" knowledge, attitudes, and practice among health care professionals. Arch Dermatol Res. 2020;312(8):545-558. doi:10.1007/s00403-020-02050-9
16. Shenefelt PD. Psychodermatological disorders: recognition and treatment. Int J Dermatol. 2011;50(11):1309-1322. doi:10.1111/j.1365-4632.2011.05096.x
17. Mercan S, Kivanç Altunay I. Psikiyatri ve dermatolojinin ortak calişma alani: Psikodermatoloji [Psychodermatology: a collaboration between psychiatry and dermatology]. Turk Psikiyatri Derg. 2006;17(4):305-313.
18. Shastri M, Sharma M, Sharma K, et al. Cutaneous-immuno-neuro-endocrine (CINE) system: a complex enterprise transforming skin into a super organ. Exp Dermatol. 2024;33(3):e15029.
19. Jin R, Luo L, Zheng J. The trinity of skin: skin homeostasis as a neuro–endocrine–immune organ. Life. 2022;12(5):725. doi:10.3390/life12050725
20. Kim J, Cho B, Cho D, Park H. Expression of hypothalamic–pituitary–adrenal axis in common skin diseases: evidence of its association with stress-related disease activity. Acta Derm Venerol. 2013;93(4):387-393. doi:10.2340/00015555-1557
21. Slominski A. Neuroendocrinology of the skin. Endocrine Reviews. 2000;21(5):457-487. doi:10.1210/er.21.5.457.
22. Arck PC, Slominski A, Theoharides TC, Peters EMJ, Paus R. Neuroimmunology of stress: skin takes center stage. Journal of Investigative Dermatology. 2006;126(8):1697-1704. doi:10.1038/sj.jid.5700104.
23. Slominski A, Wortsman J, Kohn L, et al. Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin. J Invest Dermatol. 2002;119(6):1449-1455. doi:10.1046/j.1523-1747.2002.19617.x
24. Park HJ, Kim HJ, Lee JH, et al. Corticotropin-releasing hormone (Crh) downregulates interleukin-18 expression in human hacat keratinocytes by activation of p38 mitogen-activated protein kinase (mapk) pathway. Journal of Investigative Dermatology. 2005;124(4):751-755. doi:10.1111/j.0022-202X.2005.23656.x
25. Dhabhar FS. Stress, leukocyte trafficking, and the augmentation of skin immune function. Ann N Y Acad Sci. 2003;992:205-217. doi:10.1111/j.1749-6632.2003.tb03151.x
26. Aguilera G. HPA axis responsiveness to stress: implications for healthy aging. Exp Gerontol. 2011;46(2-3):90-95. doi:10.1016/j.exger.2010.08.023
27. Glaser R, MacCallum RC, Laskowski BF, Malarkey WB, Sheridan JF, Kiecolt-Glaser JK. Evidence for a shift in the th-1 to th-2 cytokine response associated with chronic stress and aging. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 2001;56(8):M477-M482. doi:10.1093/gerona/56.8.M477
28. Dhabhar FS. Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology. Neuroimmunomodulation. 2009;16(5):300-317. doi:10.1159/000216188
29. Tausk F, Elenkov I, Moynihan J. Psychoneuroimmunology. Dermatol Ther. 2008;21(1): 22-31. doi:10.1111/j.1529-8019.2008.00166.x
30. Fortune DG, Richards HL, Griffiths CE. Psychologic factors in psoriasis: consequences, mechanisms, and interventions. Dermatol Clin. 2005;23(4):681-694. doi:10.1016/j.det.2005.05.022
31. Buske-Kirschbaum A, Ebrecht M, Hellhammer DH. Blunted HPA axis responsiveness to stress in atopic patients is associated with the acuity and severeness of allergic inflammation. Brain Behav Immun. 2010;24(8):1347-1353. doi:10.1016/j.bbi.2010.06.013
32. Lotti T, Zanardelli M, D'Erme AM. Vitiligo: what's new in the psycho-neuro-endocrine-immune connection and related treatments. Wien Med Wochenschr. 2014;164(13-14):278-285. doi:10.1007/s10354-014-0288-7
33. Ruocco V, Ruocco E, Lo Schiavo A, Brunetti G, Guerrera LP, Wolf R. Pemphigus: etiology, pathogenesis, and inducing or triggering factors: facts and controversies. Clin Dermatol. 2013;31(4):374-381. doi:10.1016/j.clindermatol.2013.01.004
34. Morell-Dubois S, Carpentier O, Cottencin O, et al. Stressful life events and pemphigus. Dermatology. 2008;216(2):104-108. doi:10.1159/000111506
35. Jović A, Marinović B, Kostović K, Čeović R, Basta-Juzbašić A, Bukvić Mokos Z. The impact of pyschological stress on acne. Acta Dermatovenerol Croat. 2017;25(2):1133-1141.
36. Mar K, Rivers JK. The mind body connection in dermatologic conditions: a literature review. J Cutan Med Surg. 2023;27(6):628-640. doi:10.1177/12034754231204295
37. Ahn D, Kim H, Lee B, Hahm DH. Psychological stress-induced pathogenesis of alopecia areata: autoimmune and apoptotic pathways. IJMS. 2023;24(14):11711. doi:10.3390/ijms241411711
38. Konstantinou GN, Konstantinou GN. Psychological stress and chronic urticaria: a neuro-immuno-cutaneous crosstalk. A systematic review of the existing evidence. Clinical Therapeutics. 2020;42(5):771-782. doi:10.1016/j.clinthera.2020.03.010
39. Chida Y, Mao X. Does psychosocial stress predict symptomatic herpes simplex virus recurrence? A meta-analytic investigation on prospective studies. Brain, Behavior, and Immunity. 2009;23(7):917-925. doi:10.1016/j.bbi.2009.04.009
40. Maarouf M, Maarouf CL, Yosipovitch G, Shi VY. The impact of stress on epidermal barrier function: an evidence-based review. Br J Dermatol. 2019;181(6):1129-1137. doi:10.1111/bjd.17605
41. Altemus M, Rao B, Dhabhar FS, Ding W, Granstein RD. Stress-induced changes in skin barrier function in healthy women. J Invest Dermatol. 2001;117(2):309-317. doi:10.1046/j.1523-1747.2001.01373.x
42. Arck P, Handjiski B, Hagen E, et al. Is there a 'gut-brain-skin axis'?. Exp Dermatol. 2010;19(5):401-405. doi:10.1111/j.1600-0625.2009.01060.x
43. Söderholm JD, Perdue MH. Stress and gastrointestinal tract. II. Stress and intestinal barrier function. Am J Physiol Gastrointest Liver Physiol. 2001;280(1):G7-G13. doi:10.1152/ajpgi.2001.280.1.G7
44. Ferreira BR, Jafferany M. Classification of psychodermatological disorders. J Cosmet Dermatol. 2021;20(6):1622-1624. doi:10.1111/jocd.14112
45. Ferreira BR, Vulink N, Mostaghimi L, et al. Classification of psychodermatological disorders: Proposal of a new international classification. Acad Dermatol Venereol. 2024;38(4):645-656. doi:10.1111/jdv.19731
46. Mehta H, Narang T. Evaluation and approach to patients with psychodermatoses. Clin Dermatol Rev. 2023;7(4):310-318. doi:10.4103/cdr.cdr_3_22
47. Jafferany M, Franca K. Psychodermatology: basics concepts. Acta Derm Venereol. 2016;96(217):35-37. doi:10.2340/00015555-2378
48. Koo J, Lebwohl A. Psycho dermatology: the mind and skin connection. Am Fam Physician. 2001;64(11):1873-1878.
49. Reichenberg JS, Kroumpouzos G, Magid M. Approach to a psychodermatology patient. G Ital Dermatol Venereol. 2018;153(4):494-496. doi:10.23736/S0392-0488.18.05965-5.
50. Marshall C, Taylor R, Bewley A. Psychodermatology in clinical practice: main principles. Acta Derm Venereol. 2016;96(217):30-34. doi:10.2340/00015555-2370
51. Torales J, García O, Barrios I, et al. Delusional infestation: clinical presentations, diagnosis, and management. J Cosmet Dermatol. 2020;19(12):3183-3188. doi:10.1111/jocd.13786
52. Campbell EH, Elston DM, Hawthorne JD, Beckert DR. Diagnosis and management of delusional parasitosis. J Am Acad Dermatol. 2019;80(5):1428-1434. doi:10.1016/j.jaad.2018.12.012
53. Beuerlein KG, Balogh EA, Feldman SR. Morgellons disease etiology and therapeutic approach: a systematic review. Dermatol Online J. 2021;27(8). doi:10.5070/D327854682
54. Wong S, Bewley A. Patients with delusional infestation (delusional parasitosis) often require prolonged treatment as recurrence of symptoms after cessation of treatment is common: an observational study. Br J Dermatol. 2011;165(4):893-896. doi:10.1111/j.1365-2133.2011.10426.x
55. American Psychiatric Association, ed. Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR. Fifth edition, text revision. American Psychiatric Association Publishing; 2022.
56. Phillips KA, Menard W, Pagano ME, Fay C, Stout RL. Delusional versus nondelusional body dysmorphic disorder: clinical features and course of illness. J Psychiatr Res. 2006;40(2):95-104. doi:10.1016/j.jpsychires.2005.08.005
57. Pereira IN, Chattopadhyay R, Fitzpatrick S, Nguyen S, Hassan H. Evidence-based review: Screening body dysmorphic disorder in aesthetic clinical settings. J Cosmet Dermatol. 2023;22(7):1951-1966. doi:10.1111/jocd.15685
58. McGrath LR, Oey L, McDonald S, Berle D, Wootton BM. Prevalence of body dysmorphic disorder: A systematic review and meta-analysis. Body Image. 2023;46:202-211. doi:10.1016/j.bodyim.2023.06.008
59. Eskander N, Limbana T, Khan F. Psychiatric comorbidities and the risk of suicide in obsessive-compulsive and body dysmorphic disorder. Cureus. 2020;12(8):e9805. Published 2020 Aug 17. doi:10.7759/cureus.9805
60. Hong K, Nezgovorova V, Uzunova G, Schlussel D, Hollander E. Pharmacological treatment of body dysmorphic disorder. Curr Neuropharmacol. 2019;17(8):697-702. doi:10.2174/1570159X16666180426153940
61. Grant JE, Stein DJ. Body-focused repetitive behavior disorders in ICD-11. Braz J Psychiatry. 2014;36 Suppl 1:59-64. doi:10.1590/1516-4446-2013-1228
62. Hautmann G, Hercogova J, Lotti T. Trichotillomania. J Am Acad Dermatol. 2002;46(6):807-826. doi:10.1067/mjd.2002.122749
63. Torales J, Ruiz Díaz N, Ventriglio A, et al. Hair-pulling disorder (Trichotillomania): etiopathogenesis, diagnosis and treatment in a nutshell. Dermatol Ther. 2021;34(1):e13466. doi:10.1111/dth.14366
64. Grant JE, Chamberlain SR. Trichotillomania. Am J Psychiatry. 2016;173(9):868-874. doi:10.1176/appi.ajp.2016.15111432
65. Jafferany M, Mkhoyan R, Stamu-O'Brien C, Carniciu S. Nonpharmacological treatment approach in trichotillomania (hair-pulling disorder). Dermatol Ther. 2020;33(4):e13622. doi:10.1111/dth.13622
66. Henkel ED, Jaquez SD, Diaz LZ. Pediatric trichotillomania: review of management. Pediatr Dermatol. 2019;36(6):803-807. doi:10.1111/pde.13954
67. Everett GJ, Jafferany M, Skurya J. Recent advances in the treatment of trichotillomania (hair-pulling disorder). Dermatol Ther. 2020;33(6):e13818. doi:10.1111/dth.13818
68. Hoffman J, Williams T, Rothbart R, et al. Pharmacotherapy for trichotillomania. Cochrane Database Syst Rev. 2021;9(9). doi:10.1002/14651858.CD007662.pub3
69. Odlaug BL, Grant JE. Phenomenology and epidemiology of pathological skin picking. In: Grant JE, Potenza MN, eds. The Oxford Handbook of Impulse Control Disorders. 1st ed. Oxford University Press; 2012:187-195. doi:10.1093/oxfordhb/9780195389715.013.0070
70. Flessner CA, Woods DW. Phenomenological characteristics, social problems, and the economic impact associated with chronic skin picking. Behav Modif. 2006;30(6):944-963. doi:10.1177/0145445506294083
71. Odlaug BL, Grant JE. Clinical characteristics and medical complications of pathologic skin picking. Gen Hosp Psychiatry. 2008;30(1):61-66. doi:10.1016/j.genhosppsych.2007.07.009
72. Torales J, Díaz NR, Barrios I, et al. Psychodermatology of skin picking (excoriation disorder): A comprehensive review. Dermatol Ther. 2020;33(4):e13661. doi:10.1111/dth.13661
73. Lochner C, Roos A, Stein DJ. Excoriation (skin-picking) disorder: a systematic review of treatment options. Neuropsychiatr Dis Treat. 2017;13:1867-1872.
74. Chandran V, Kurien G. Dermatitis artefacta. In: StatPearls. StatPearls Publishing; 2024. Accessed October 4, 2024. http://www.ncbi.nlm.nih.gov/books/NBK430936/
75. Mohandas P, Ravenscroft JC, Bewley A. Dermatitis artefacta in childhood and adolescence: a spectrum of disease. G Ital Dermatol Venereol. 2018;153(4):525-534. doi:10.23736/S0392-0488.18.06019-4
76. Verraes-Derancourt S, Derancourt C, Poot F, Heenen M, Bernard P. Dermatitis artefacta: retrospective study in 31 patients. Ann Dermatol Venereol. 2006;133(3):235-8. doi:10.1016/S0151-9638(06)70886-9
77. Koblenzer CS. Dermatitis artefacta. Clinical features and approaches to treatment. Am J Clin Dermatol. 2000;1(1):47-55. doi:10.2165/00128071-200001010-00005
78. Alozai U ullah, McPherson PK. Malingering. In: StatPearls. StatPearls Publishing; 2024. Accessed August 1, 2024. http://www.ncbi.nlm.nih.gov/books/NBK507837/
79. Marzouki-Zerouali A, Schoeffler A, Liegeon AL, Le Vaou P, Truchetet F. Lésions auto-provoquées dans un contexte d’hidradénite suppurée : un cas de pathomimicrie [Self-inflicted lesions in the context of hidradenitis suppurativa: Pathomimicry]. Annales de Dermatologie et de Vénéréologie. 2019;146(2):135-140. doi:10.1016/j.annder.2018.07.028
80. Hariharasubramony A, Chankramath S, Srinivasa S. Munchausen syndrome as dermatitis simulata. Indian J Psychol Med. 2012;34(1):94-96. doi:10.4103/0253-7176.96171
81. Nayak K, Gopinath H, Kini H, Kumar P. Unmasking Diogenes syndrome. Indian J Dermatol. 2015;60(3):287-289. doi:10.4103/0019-5154.156385
82. Bonamonte D, Foti C, DE Marco A, et al. Self-inflicted pathological cutaneous disorders. Part I. Ital J Dermatol Venerol. 2022;157(5):389-401. doi:10.23736/S2784-8671.22.07273-5
83. Brown RC, Plener PL. Non-suicidal self-injury in adolescence. Curr Psychiatry Rep. 2017;19(3):20. doi:10.1007/s11920-017-0767-9
84. Misery L, Alexandre S, Dutray S, et al. Functional itch disorder or psychogenic pruritus: suggested diagnosis criteria from the French psychodermatology group. Acta Derm Venereol. 2007;87(4):341-344. doi:10.2340/00015555-0266
85. Gieler U, Niemeier V, Brosig B, Kupfer J. Psychosomatic aspects of pruritus. Dermatol Psychosom. 2002;3(1):6-13. doi:10.1159/000051357
86. Salari N, Heidarian P, Hosseinian-Far A, Babajani F, Mohammadi M. Global prevalence of anxiety, depression, and stress among patients with skin diseases: a systematic review and meta-analysis. J of Prevention. 2024;45(4):611-649. doi:10.1007/s10935-024-00784-0
87. Dalgard FJ, Gieler U, Tomas-Aragones L, et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol. 2015;135(4):984-991. doi:10.1038/jid.2014.530
88. Picardi A, Mazzotti E, Pasquini P. Prevalence and correlates of suicidal ideation among patients with skin disease. J Am Acad Dermatol. 2006;54(3):420-426. doi:10.1016/j.jaad.2005.11.1103
89. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol. 1998;139(5):846-850. doi:10.1046/j.1365-2133.1998.02511.x
90. Alharbi M. Identifying patients at higher risk of depression among patients with vitiligo at outpatient setting. Mater Sociomed. 2020;32(2):108. doi:10.5455/msm.2020.32.108-111
91. Molla A, Jannadi R, Alayoubi H, Altouri H, Balkhair M, Hafez D. Assessing the relationship between vitiligo and major depressive disorder severity: cross-sectional study. JMIR Dermatol. 2024;7:e60686. doi:10.2196/60686
92. Bakar RS, Jaapar SZS, Azmi AF, Aun YC. Depression and anxiety among patients with psoriasis: A correlation with quality of life and associated factors. J Taibah Univ Med Sci. 2021;16(4):491-496. doi:10.1016/j.jtumed.2021.02.008
93. Mostafa N, Smith SD. Improving psychological health outcomes in children with atopic dermatitis. Clin Cosmet Investig Dermatol. 2023;16:2821-2827. doi:10.2147/CCID.S393254
94. Holmes A, Marella P, Rodriguez C, Glass, Ii D, Goerlich KS. Alexithymia and cutaneous disease morbidity: a systematic review. Dermatology. 2022;238(6):1120-1129. doi:10.1159/000524736
95. Balon R, Wise TN, eds. Clinical Challenges in the Biopsychosocial Interface: Update on Psychosomatics for the 21st Century. Karger; 2015.
96. Yadav S, Narang T, Kumaran MS. Psychodermatology: a comprehensive review. Indian J Dermatol Venereol Leprol. 2013;79(2):176-192. doi:10.4103/0378-6323.107632
97. D'Erme AM, Zanieri F, Campolmi E, et al. Therapeutic implications of adding the psychotropic drug escitalopram in the treatment of patients suffering from moderate-severe psoriasis and psychiatric comorbidity: a retrospective study. J Eur Acad Dermatol Venereol. 2014;28(2):246-249. doi:10.1111/j.1468-3083.2012.04690.x
98. Voss RM, Das JM. Mental status examination. In: StatPearls. StatPearls Publishing; 2024. Accessed October 5, 2024. http://www.ncbi.nlm.nih.gov/books/NBK546682/
99. Jafferany M, Ferreira BR, Abdelmaksoud A, Mkhoyan R. Management of psychocutaneous disorders: A practical approach for dermatologists. Dermatol Ther. 2020;33(6):e13969. doi:10.1111/dth.13969
100. Patel A, Jafferany M. Multidisciplinary and holistic models of care for patients with dermatologic disease and psychosocial comorbidity: a systematic review. JAMA Dermatol. 2020;156(6):686. doi:10.1001/jamadermatol.2020.0394
101. Ferreira BR, Pio‐Abreu JL, Reis JP, Figueiredo A. First psychodermatology clinic in a portuguese department of dermatology. Acad Dermatol Venereol. 2019;33(3). doi:10.1111/jdv.15303
102. Poot F, Sampogna F, Onnis L. Basic knowledge in psychodermatology. J Eur Acad Dermatol Venereol. 2007;21(2):227-234. doi:10.1111/j.1468-3083.2006.01910.x
103. Shenoi SD, Prabhu S, Nirmal B, Petrolwala S. Our experience in a psychodermatology liaison clinic at manipal, India. Indian J Dermatol. 2013;58(1):53-55. doi:10.4103/0019-5154.105310
104. Goyal N, Shenoi S, Prabhu SS, Sreejayan K, Munoli R, Rai S. Psychodermatology liaison clinic in India: a working model. Trop Doct. 2018;48(1):7-11. doi:10.1177/0049475517736708
105. Seale L, Gaulding JV, Porto D, Prabhakar D, Kerr H. Implementation of a psychodermatology clinic at a major health system in Detroit. Int J Women’s Dermatol. 2018;4(4):227-229. doi:10.1016/j.ijwd.2018.05.002
106. Healy R, Taylor R, Dhoat S, Leschynska E, Bewley AP. Management of patients with delusional parasitosis in a joint dermatology/ liaison psychiatry clinic. Br J Dermatol. 2009;161(1):197-199. doi:10.1111/j.1365-2133.2009.09183.x
107. Altaf K, Mohandas P, Marshall C, Taylor R, Bewley A. Managing patients with delusional infestations in an integrated psychodermatology clinic is much more cost-effective than a general dermatology or primary care setting. Br J Dermatol. 2017;177(2):544-545. doi:10.1111/bjd.15088
108. Christensen RE, Jafferany M. Unmet Needs in Psychodermatology: A Narrative Review. CNS Drugs. 2024;38(3):193-204. doi:10.1007/s40263-024-01068-1
109. Altaha L, Jafferany M, Khan A. Psychocutaneous medicine in iraq: current status and recommendations. Prim Care Companion CNS Disord. 2022;24(2). doi:10.4088/PCC.21m03077
110. Jafferany M, Vander Stoep A, Dumitrescu A, Hornung RL. The knowledge, awareness, and practice patterns of dermatologists toward psychocutaneous disorders: results of a survey study. Int J Dermatol. 2010;49(7):784-789. doi:10.1111/j.1365-4632.2009.04372.x